Laboratoires Euromedis Société anonyme (EPA:ALEMG)

EPA:ALEMG Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	19.14	16.67	15.18	-	26.8	31.86
Cash & Short-Term Investments	19.14	16.67	15.18	-	26.8	31.86
Cash Growth	18.87%	9.83%	-	-	-15.88%	102.48%
Accounts Receivable	11.75	9.73	7.75	8.51	8.85	14.04
Other Receivables	1.52	1.05	0.89	1.08	2.29	5.12
Receivables	13.27	10.77	8.64	9.59	11.14	19.15
Inventory	-	10.78	13.77	10.81	12.59	11.76
Prepaid Expenses	-	0.02	0.06	0.06	0.18	0.16
Other Current Assets	-	0	0	18.84	1.17	1.47
Total Current Assets	32.41	38.24	37.65	39.3	51.87	64.41
Property, Plant & Equipment	0.22	0.69	0.81	0.63	4.32	4.4
Long-Term Investments	9.94	0.2	0.21	6.21	0.88	0.9
Goodwill	-	-	-	-	2.54	2.63
Other Intangible Assets	0.32	0.3	0.05	0.03	0.09	0.14
Other Long-Term Assets	0.23	0.06	0.06	0.09	0.16	0.25
Total Assets	43.12	39.49	38.79	46.26	59.87	72.72

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	8.75	9.92	9.54	7.81	7.31	10.5
Accrued Expenses	-	-	-	-	1.61	1.86
Short-Term Debt	-	-	-	-	0	0.54
Current Portion of Long-Term Debt	-	0.99	-	-	-	-
Current Income Taxes Payable	-	1.44	1.12	1.1	-	-
Current Unearned Revenue	-	-	-	-	0.03	0.21
Other Current Liabilities	4.78	-	-	-	0.52	0.31
Total Current Liabilities	13.53	12.36	10.66	8.9	9.48	13.42
Long-Term Debt	5.25	5.11	8.04	10.02	12.73	14.63
Long-Term Leases	-	-	-	-	0.11	0.36
Long-Term Unearned Revenue	-	-	-	-	0.07	0.24
Long-Term Deferred Tax Liabilities	-	-	-	-	0.33	0.35
Other Long-Term Liabilities	4.02	5.61	3.61	4.75	2.27	2.48
Total Liabilities	22.81	23.08	22.3	23.67	24.99	31.48

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	5.77	5.77	5.75	5.75	6.02	6.02
Additional Paid-In Capital	9.76	9.76	9.73	9.73	9.21	9.21
Retained Earnings	4.78	-1.76	-1.63	4.48	-5.93	2.26
Treasury Stock	-	-	-	-	-0.42	-0.21
Comprehensive Income & Other	-	2.63	2.63	2.63	25.82	23.72
Total Common Equity	20.32	16.41	16.48	22.59	34.7	41
Minority Interest	-	-	-	-	0.18	0.24
Shareholders' Equity	20.32	16.41	16.48	22.59	34.88	41.24
Total Liabilities & Equity	43.12	39.49	38.79	46.26	59.87	72.72

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	5.25	6.11	8.04	10.02	12.84	15.53
Net Cash (Debt)	13.89	10.57	7.14	-10.02	13.96	16.33
Net Cash Growth	80.53%	47.91%	-	-	-14.49%	-
Net Cash Per Share	-	3.70	2.51	-3.52	4.78	4.56
Filing Date Shares Outstanding	-	2.86	2.84	2.85	2.92	2.99
Total Common Shares Outstanding	-	2.86	2.84	2.85	2.92	2.99
Working Capital	18.88	25.88	26.99	30.39	42.39	50.99
Book Value Per Share	-	5.75	5.80	7.93	11.87	13.71
Tangible Book Value	20	16.11	16.43	22.56	32.07	38.23
Tangible Book Value Per Share	-	5.64	5.78	7.92	10.97	12.78
Land	-	0.27	-	-	0.32	0.32
Buildings	-	0.61	-	-	3.56	3.51
Machinery	-	-	-	-	7.04	6.61
Construction In Progress	-	0.02	-	-	0.11	0.1

Data Source: S&P Global Market Intelligence Last updated: Apr 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 3, 2026

Data Sources Report a data error